25 XP   0   0   10

Guizhou Yibai Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Guizhou Yibai Pharmaceutical Co Ltd together

PenkeI guess you are interested in Guizhou Yibai Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guizhou Yibai Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Guizhou Yibai Pharmaceutical Co Ltd

I send you an email if I find something interesting about Guizhou Yibai Pharmaceutical Co Ltd.

Quick analysis of Guizhou Yibai Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Guizhou Yibai Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥4.03
Expected worth in 1 year
¥2.15
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
¥-1.63
Return On Investment
-42.0%

For what price can you sell your share?

Current Price per Share
¥3.89
Expected price per share
¥3.8 - ¥4.91
How sure are you?
50%

1. Valuation of Guizhou Yibai Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥3.89

Intrinsic Value Per Share

¥-1.40 - ¥1.55

Total Value Per Share

¥2.63 - ¥5.58

2. Growth of Guizhou Yibai Pharmaceutical Co Ltd (5 min.)




Is Guizhou Yibai Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$440.8m$492.3m-$51.4m-11.7%

How much money is Guizhou Yibai Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$58.9m$33.6m-$92.6m-157.2%
Net Profit Margin-15.6%7.3%--

How much money comes from the company's main activities?

3. Financial Health of Guizhou Yibai Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Guizhou Yibai Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Guizhou Yibai Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Guizhou Yibai Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Guizhou Yibai Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Guizhou Yibai Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Guizhou Yibai Pharmaceutical Co Ltd is ¥3.89. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Guizhou Yibai Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Guizhou Yibai Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.03. Based on the TTM, the Book Value Change Per Share is ¥-0.47 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Guizhou Yibai Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.07-1.9%-0.07-1.9%0.041.1%-0.02-0.5%0.020.6%
Usd Book Value Change Per Share-0.07-1.7%-0.07-1.7%0.020.4%-0.05-1.3%0.030.7%
Usd Dividend Per Share0.010.2%0.010.2%0.030.7%0.030.8%0.020.6%
Usd Total Gains Per Share-0.06-1.5%-0.06-1.5%0.041.1%-0.02-0.5%0.051.3%
Usd Price Per Share0.76-0.76-1.12-0.81-1.98-
Price to Earnings Ratio-10.27--10.27-26.41-11.20-31.52-
Price-to-Total Gains Ratio-13.54--13.54-25.61--0.84-18.83-
Price to Book Ratio1.37-1.37-1.81-1.31-3.71-
Price-to-Total Gains Ratio-13.54--13.54-25.61--0.84-18.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.537598
Number of shares1860
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.03
Usd Book Value Change Per Share-0.07-0.05
Usd Total Gains Per Share-0.06-0.02
Gains per Quarter (1860 shares)-104.98-35.93
Gains per Year (1860 shares)-419.91-143.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
164-484-430246-389-154
2128-967-850491-778-298
3191-1451-1270737-1168-442
4255-1935-1690982-1557-586
5319-2418-21101228-1946-730
6383-2902-25301473-2335-874
7446-3386-29501719-2725-1018
8510-3869-33701964-3114-1162
9574-4353-37902210-3503-1306
10638-4837-42102455-3892-1450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%19.02.01.086.4%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%6.04.00.060.0%17.05.00.077.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.02.090.9%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%2.03.00.040.0%7.03.00.070.0%18.04.00.081.8%

Fundamentals of Guizhou Yibai Pharmaceutical Co Ltd

About Guizhou Yibai Pharmaceutical Co Ltd

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatism, digestive system, pediatric, gynecological, anti-infection, anti-inflammatory, analgesic, and other diseases. The company was founded in 1995 and is based in Guiyang, China.

Fundamental data was last updated by Penke on 2024-04-17 08:57:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Guizhou Yibai Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Guizhou Yibai Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Guizhou Yibai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -15.6% means that ¥-0.16 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guizhou Yibai Pharmaceutical Co Ltd:

  • The MRQ is -15.6%. The company is making a huge loss. -2
  • The TTM is -15.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-15.6%TTM-15.6%0.0%
TTM-15.6%YOY7.3%-22.9%
TTM-15.6%5Y-3.2%-12.4%
5Y-3.2%10Y4.1%-7.3%
1.1.2. Return on Assets

Shows how efficient Guizhou Yibai Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Guizhou Yibai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -8.8% Return on Assets means that Guizhou Yibai Pharmaceutical Co Ltd generated ¥-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guizhou Yibai Pharmaceutical Co Ltd:

  • The MRQ is -8.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.8%TTM-8.8%0.0%
TTM-8.8%YOY4.8%-13.6%
TTM-8.8%5Y-1.7%-7.1%
5Y-1.7%10Y2.8%-4.5%
1.1.3. Return on Equity

Shows how efficient Guizhou Yibai Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Guizhou Yibai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -14.0% Return on Equity means Guizhou Yibai Pharmaceutical Co Ltd generated ¥-0.14 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guizhou Yibai Pharmaceutical Co Ltd:

  • The MRQ is -14.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.0%TTM-14.0%0.0%
TTM-14.0%YOY7.0%-21.0%
TTM-14.0%5Y-3.4%-10.6%
5Y-3.4%10Y4.3%-7.7%

1.2. Operating Efficiency of Guizhou Yibai Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Guizhou Yibai Pharmaceutical Co Ltd is operating .

  • Measures how much profit Guizhou Yibai Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Guizhou Yibai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 9.9% means the company generated ¥0.10  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guizhou Yibai Pharmaceutical Co Ltd:

  • The MRQ is 9.9%. The company is operating less efficient.
  • The TTM is 9.9%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ9.9%TTM9.9%0.0%
TTM9.9%YOY12.9%-3.1%
TTM9.9%5Y10.8%-1.0%
5Y10.8%10Y8.5%+2.3%
1.2.2. Operating Ratio

Measures how efficient Guizhou Yibai Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.19 means that the operating costs are ¥1.19 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guizhou Yibai Pharmaceutical Co Ltd:

  • The MRQ is 1.192. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.192. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.192TTM1.1920.000
TTM1.192YOY1.063+0.129
TTM1.1925Y1.124+0.068
5Y1.12410Y0.830+0.293

1.3. Liquidity of Guizhou Yibai Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Guizhou Yibai Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.74 means the company has ¥1.74 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guizhou Yibai Pharmaceutical Co Ltd:

  • The MRQ is 1.740. The company is able to pay all its short-term debts. +1
  • The TTM is 1.740. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.740TTM1.7400.000
TTM1.740YOY1.593+0.147
TTM1.7405Y1.787-0.046
5Y1.78710Y1.183+0.604
1.3.2. Quick Ratio

Measures if Guizhou Yibai Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Guizhou Yibai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.25 means the company can pay off ¥0.25 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guizhou Yibai Pharmaceutical Co Ltd:

  • The MRQ is 0.251. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.251. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.251TTM0.2510.000
TTM0.251YOY0.316-0.065
TTM0.2515Y0.472-0.221
5Y0.47210Y0.567-0.094

1.4. Solvency of Guizhou Yibai Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Guizhou Yibai Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Guizhou Yibai Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.34 means that Guizhou Yibai Pharmaceutical Co Ltd assets are financed with 34.4% credit (debt) and the remaining percentage (100% - 34.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guizhou Yibai Pharmaceutical Co Ltd:

  • The MRQ is 0.344. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.344. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.344TTM0.3440.000
TTM0.344YOY0.297+0.047
TTM0.3445Y0.341+0.003
5Y0.34110Y0.354-0.013
1.4.2. Debt to Equity Ratio

Measures if Guizhou Yibai Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Guizhou Yibai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 55.1% means that company has ¥0.55 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guizhou Yibai Pharmaceutical Co Ltd:

  • The MRQ is 0.551. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.551. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.551TTM0.5510.000
TTM0.551YOY0.430+0.121
TTM0.5515Y0.550+0.001
5Y0.55010Y0.575-0.025

2. Market Valuation of Guizhou Yibai Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Guizhou Yibai Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Guizhou Yibai Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -10.27 means the investor is paying ¥-10.27 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guizhou Yibai Pharmaceutical Co Ltd:

  • The EOD is -7.224. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.269. Based on the earnings, the company is expensive. -2
  • The TTM is -10.269. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.224MRQ-10.269+3.045
MRQ-10.269TTM-10.2690.000
TTM-10.269YOY26.411-36.680
TTM-10.2695Y11.196-21.465
5Y11.19610Y31.521-20.324
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guizhou Yibai Pharmaceutical Co Ltd:

  • The EOD is 137.680. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 195.725. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 195.725. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD137.680MRQ195.725-58.045
MRQ195.725TTM195.7250.000
TTM195.725YOY13.236+182.489
TTM195.7255Y10.080+185.645
5Y10.08010Y65.783-55.703
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Guizhou Yibai Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Guizhou Yibai Pharmaceutical Co Ltd:

  • The EOD is 0.966. Based on the equity, the company is cheap. +2
  • The MRQ is 1.373. Based on the equity, the company is underpriced. +1
  • The TTM is 1.373. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.966MRQ1.373-0.407
MRQ1.373TTM1.3730.000
TTM1.373YOY1.807-0.434
TTM1.3735Y1.308+0.065
5Y1.30810Y3.710-2.403
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Guizhou Yibai Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.470-0.4700%0.125-475%-0.379-20%0.208-327%
Book Value Per Share--4.0284.0280%4.498-10%4.520-11%4.519-11%
Current Ratio--1.7401.7400%1.593+9%1.787-3%1.183+47%
Debt To Asset Ratio--0.3440.3440%0.297+16%0.341+1%0.354-3%
Debt To Equity Ratio--0.5510.5510%0.430+28%0.550+0%0.575-4%
Dividend Per Share--0.0620.0620%0.192-68%0.239-74%0.166-63%
Eps---0.539-0.5390%0.308-275%-0.136-75%0.168-420%
Free Cash Flow Per Share--0.0280.0280%0.614-95%0.135-79%0.219-87%
Free Cash Flow To Equity Per Share--0.2410.2410%0.002+13356%-0.347+244%0.198+22%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--1.548--------
Intrinsic Value_10Y_min---1.403--------
Intrinsic Value_1Y_max--0.205--------
Intrinsic Value_1Y_min--0.066--------
Intrinsic Value_3Y_max--0.579--------
Intrinsic Value_3Y_min--0.021--------
Intrinsic Value_5Y_max--0.906--------
Intrinsic Value_5Y_min---0.219--------
Market Cap3080595936.640-42%4379358522.0004379358522.0000%6438369762.000-32%4653365402.400-6%11359402222.784-61%
Net Profit Margin---0.156-0.1560%0.073-314%-0.032-79%0.041-482%
Operating Margin--0.0990.0990%0.129-24%0.108-9%0.085+16%
Operating Ratio--1.1921.1920%1.063+12%1.124+6%0.830+44%
Pb Ratio0.966-42%1.3731.3730%1.807-24%1.308+5%3.710-63%
Pe Ratio-7.224+30%-10.269-10.2690%26.411-139%11.196-192%31.521-133%
Price Per Share3.890-42%5.5305.5300%8.130-32%5.876-6%14.344-61%
Price To Free Cash Flow Ratio137.680-42%195.725195.7250%13.236+1379%10.080+1842%65.783+198%
Price To Total Gains Ratio-9.525+30%-13.541-13.5410%25.605-153%-0.839-94%18.830-172%
Quick Ratio--0.2510.2510%0.316-20%0.472-47%0.567-56%
Return On Assets---0.088-0.0880%0.048-282%-0.017-81%0.028-408%
Return On Equity---0.140-0.1400%0.070-301%-0.034-76%0.043-423%
Total Gains Per Share---0.408-0.4080%0.318-229%-0.140-66%0.373-209%
Usd Book Value--440847795.572440847795.5720%492330860.444-10%494658691.193-11%494550049.292-11%
Usd Book Value Change Per Share---0.065-0.0650%0.017-475%-0.052-20%0.029-327%
Usd Book Value Per Share--0.5570.5570%0.622-10%0.625-11%0.624-11%
Usd Dividend Per Share--0.0090.0090%0.027-68%0.033-74%0.023-63%
Usd Eps---0.074-0.0740%0.043-275%-0.019-75%0.023-420%
Usd Free Cash Flow--3092230.2283092230.2280%67224961.095-95%14763458.746-79%23935504.715-87%
Usd Free Cash Flow Per Share--0.0040.0040%0.085-95%0.019-79%0.030-87%
Usd Free Cash Flow To Equity Per Share--0.0330.0330%0.000+13356%-0.048+244%0.027+22%
Usd Market Cap425738358.444-42%605227347.740605227347.7400%889782701.108-32%643095098.612-6%1569869387.189-61%
Usd Price Per Share0.538-42%0.7640.7640%1.124-32%0.812-6%1.982-61%
Usd Profit---58937766.537-58937766.5370%33689390.946-275%-14857537.623-75%18405874.714-420%
Usd Revenue--378013324.304378013324.3040%462514576.509-18%462667321.403-18%462655122.214-18%
Usd Total Gains Per Share---0.056-0.0560%0.044-229%-0.019-66%0.052-209%
 EOD+4 -4MRQTTM+0 -0YOY+6 -295Y+4 -3110Y+9 -26

3.2. Fundamental Score

Let's check the fundamental score of Guizhou Yibai Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.224
Price to Book Ratio (EOD)Between0-10.966
Net Profit Margin (MRQ)Greater than0-0.156
Operating Margin (MRQ)Greater than00.099
Quick Ratio (MRQ)Greater than10.251
Current Ratio (MRQ)Greater than11.740
Debt to Asset Ratio (MRQ)Less than10.344
Debt to Equity Ratio (MRQ)Less than10.551
Return on Equity (MRQ)Greater than0.15-0.140
Return on Assets (MRQ)Greater than0.05-0.088
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Guizhou Yibai Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.678
Ma 20Greater thanMa 504.609
Ma 50Greater thanMa 1004.590
Ma 100Greater thanMa 2005.144
OpenGreater thanClose3.880
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,865,808
Total Liabilities1,675,881
Total Stockholder Equity3,044,226
 As reported
Total Liabilities 1,675,881
Total Stockholder Equity+ 3,044,226
Total Assets = 4,865,808

Assets

Total Assets4,865,808
Total Current Assets2,040,631
Long-term Assets2,825,176
Total Current Assets
Cash And Cash Equivalents 592,355
Net Receivables 294,527
Inventory 625,085
Other Current Assets 44,907
Total Current Assets  (as reported)2,040,631
Total Current Assets  (calculated)1,556,874
+/- 483,757
Long-term Assets
Property Plant Equipment 1,822,971
Goodwill 164,038
Intangible Assets 362,032
Other Assets 434,528
Long-term Assets  (as reported)2,825,176
Long-term Assets  (calculated)2,783,569
+/- 41,607

Liabilities & Shareholders' Equity

Total Current Liabilities1,172,715
Long-term Liabilities503,166
Total Stockholder Equity3,044,226
Total Current Liabilities
Short Long Term Debt 537,110
Accounts payable 149,428
Other Current Liabilities 258,033
Total Current Liabilities  (as reported)1,172,715
Total Current Liabilities  (calculated)944,571
+/- 228,145
Long-term Liabilities
Long term Debt 343,038
Capital Lease Obligations Min Short Term Debt29,296
Other Liabilities 130,831
Long-term Liabilities Other 649
Deferred Long Term Liability 145,718
Long-term Liabilities  (as reported)503,166
Long-term Liabilities  (calculated)649,534
+/- 146,368
Total Stockholder Equity
Common Stock791,927
Retained Earnings 1,517,473
Other Stockholders Equity 989
Total Stockholder Equity (as reported)3,044,226
Total Stockholder Equity (calculated)2,310,390
+/- 733,837
Other
Capital Stock791,927
Common Stock Shares Outstanding 791,927
Net Debt 287,793
Net Invested Capital 3,924,375
Net Tangible Assets 2,518,157
Net Working Capital 867,916
Property Plant and Equipment Gross 1,822,971



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
> Total Assets 
217,807
303,069
455,143
867,798
1,200,047
987,968
1,140,272
1,218,781
1,282,212
1,564,867
1,803,695
2,276,882
3,200,872
5,495,675
5,587,579
6,588,915
7,194,495
6,475,568
5,618,016
5,226,387
5,068,039
4,865,808
4,865,8085,068,0395,226,3875,618,0166,475,5687,194,4956,588,9155,587,5795,495,6753,200,8722,276,8821,803,6951,564,8671,282,2121,218,7811,140,272987,9681,200,047867,798455,143303,069217,807
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,532,237
2,652,615
3,120,999
2,722,059
2,284,178
1,719,982
2,040,631
2,040,6311,719,9822,284,1782,722,0593,120,9992,652,6152,532,237000000000000000
       Cash And Cash Equivalents 
36,610
87,930
61,227
113,663
109,254
132,321
139,297
160,018
188,804
189,917
164,846
192,427
148,688
1,052,858
1,049,749
1,025,333
1,165,547
550,799
1,023,385
617,434
379,628
592,355
592,355379,628617,4341,023,385550,7991,165,5471,025,3331,049,7491,052,858148,688192,427164,846189,917188,804160,018139,297132,321109,254113,66361,22787,93036,610
       Net Receivables 
57,957
77,811
104,842
264,892
415,474
136,605
253,020
271,901
455,397
674,775
824,750
968,870
1,090,690
1,003,082
968,662
1,157,404
1,117,813
1,084,444
1,116,964
316,870
340,875
294,527
294,527340,875316,8701,116,9641,084,4441,117,8131,157,404968,6621,003,0821,090,690968,870824,750674,775455,397271,901253,020136,605415,474264,892104,84277,81157,957
       Other Current Assets 
6,218
2,772
3,800
57,321
164,435
134,179
105,390
35,417
58,743
101,353
134,546
413,744
472,602
298,297
353,288
69,211
36,760
1,112,205
128,764
48,745
48,651
44,907
44,90748,65148,745128,7641,112,20536,76069,211353,288298,297472,602413,744134,546101,35358,74335,417105,390134,179164,43557,3213,8002,7726,218
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,056,678
4,541,880
3,354,570
2,895,957
2,942,208
3,348,057
2,825,176
2,825,1763,348,0572,942,2082,895,9573,354,5704,541,8804,056,678000000000000000
       Property Plant Equipment 
35,642
51,585
173,798
301,546
326,542
323,300
391,426
432,742
312,635
335,518
296,770
294,901
544,975
726,131
990,016
1,336,455
1,544,585
1,421,552
1,287,634
1,416,284
1,705,703
1,822,971
1,822,9711,705,7031,416,2841,287,6341,421,5521,544,5851,336,455990,016726,131544,975294,901296,770335,518312,635432,742391,426323,300326,542301,546173,79851,58535,642
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,618,175
1,618,175
2,068,182
2,168,151
861,406
772,450
631,733
777,662
164,038
164,038777,662631,733772,450861,4062,168,1512,068,1821,618,1751,618,1750000000000000
       Intangible Assets 
2,777
2,720
15,360
17,634
34,738
62,505
68,434
77,502
65,347
43,172
106,971
89,596
89,766
1,974,422
1,953,825
367,403
357,144
367,990
393,586
341,968
378,540
362,032
362,032378,540341,968393,586367,990357,144367,4031,953,8251,974,42289,76689,596106,97143,17265,34777,50268,43462,50534,73817,63415,3602,7202,777
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
157,798
273,577
288,952
62,043
144,162
72,401
63,175
63,17572,401144,16262,043288,952273,577157,798000000000000000
> Total Liabilities 
135,178
174,867
274,925
361,102
652,653
562,274
610,235
620,624
571,263
688,816
665,509
731,326
1,268,413
2,054,027
2,002,035
2,348,832
2,505,611
2,517,633
1,894,976
1,763,261
1,505,587
1,675,881
1,675,8811,505,5871,763,2611,894,9762,517,6332,505,6112,348,8322,002,0352,054,0271,268,413731,326665,509688,816571,263620,624610,235562,274652,653361,102274,925174,867135,178
   > Total Current Liabilities 
127,180
169,517
212,838
274,062
607,613
542,234
590,195
620,564
541,003
667,145
642,553
656,405
1,212,767
1,754,283
1,702,099
1,926,802
1,680,191
1,983,540
1,072,296
1,536,057
1,079,388
1,172,715
1,172,7151,079,3881,536,0571,072,2961,983,5401,680,1911,926,8021,702,0991,754,2831,212,767656,405642,553667,145541,003620,564590,195542,234607,613274,062212,838169,517127,180
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,077,553
820,553
992,122
0
0
0
0
0000992,122820,5531,077,553000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,077,553
820,553
992,122
545,553
745,553
454,453
537,110
537,110454,453745,553545,553992,122820,5531,077,553000000000000000
       Accounts payable 
16,832
22,766
31,918
28,081
51,755
51,795
54,957
48,871
65,479
48,306
90,014
51,329
83,841
98,677
158,483
150,116
150,292
109,146
97,697
84,724
108,474
149,428
149,428108,47484,72497,697109,146150,292150,116158,48398,67783,84151,32990,01448,30665,47948,87154,95751,79551,75528,08131,91822,76616,832
       Other Current Liabilities 
26,698
53,601
62,270
161,331
279,208
152,789
243,709
315,943
245,324
339,239
303,639
354,576
747,403
1,146,083
611,740
557,233
516,546
785,623
350,430
265,245
300,582
258,033
258,033300,582265,245350,430785,623516,546557,233611,7401,146,083747,403354,576303,639339,239245,324315,943243,709152,789279,208161,33162,27053,60126,698
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
422,030
825,419
581,434
822,680
227,204
426,199
503,166
503,166426,199227,204822,680581,434825,419422,030000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,077,553
-820,553
-992,122
0
0
12,412
29,296
29,29612,41200-992,122-820,553-1,077,553000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
377,000
755,059
515,299
775,772
65,749
0
649
649065,749775,772515,299755,059377,000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
88,162
160,715
214,247
183,725
172,700
169,813
145,718
145,718169,813172,700183,725214,247160,71588,162000000000000000
> Total Stockholder Equity
82,629
128,202
179,760
507,643
556,229
423,443
511,749
579,375
701,182
866,169
1,125,982
1,538,778
1,923,825
3,430,250
3,572,116
3,940,357
4,280,028
3,503,441
3,600,772
3,365,165
3,503,200
3,044,226
3,044,2263,503,2003,365,1653,600,7723,503,4414,280,0283,940,3573,572,1163,430,2501,923,8251,538,7781,125,982866,169701,182579,375511,749423,443556,229507,643179,760128,20282,629
   Common Stock
47,000
47,000
47,000
67,000
80,400
120,600
180,900
235,170
235,170
352,755
352,755
360,701
360,625
395,964
791,927
791,927
791,927
791,927
791,927
791,927
791,927
791,927
791,927791,927791,927791,927791,927791,927791,927791,927395,964360,625360,701352,755352,755235,170235,170180,900120,60080,40067,00047,00047,00047,000
   Retained Earnings 
30,293
69,030
112,983
159,533
209,463
65,563
140,367
197,016
307,786
401,962
632,206
906,378
1,244,325
1,869,935
2,011,801
2,380,042
2,720,056
1,907,623
2,049,518
1,803,118
1,943,941
1,517,473
1,517,4731,943,9411,803,1182,049,5181,907,6232,720,0562,380,0422,011,8011,869,9351,244,325906,378632,206401,962307,786197,016140,36765,563209,463159,533112,98369,03030,293
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,435
1,731
1,187
989
9891,1871,7312,435000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,772,886
Cost of Revenue-857,932
Gross Profit1,914,9531,914,953
 
Operating Income (+$)
Gross Profit1,914,953
Operating Expense-2,510,971
Operating Income261,914-596,018
 
Operating Expense (+$)
Research Development121,947
Selling General Administrative1,332,220
Selling And Marketing Expenses-
Operating Expense2,510,9711,454,168
 
Net Interest Income (+$)
Interest Income6,515
Interest Expense-27,379
Other Finance Cost-1,203
Net Interest Income-19,661
 
Pretax Income (+$)
Operating Income261,914
Net Interest Income-19,661
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-436,992261,914
EBIT - interestExpense = -27,379
-452,597
-425,218
Interest Expense27,379
Earnings Before Interest and Taxes (EBIT)--409,613
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-436,992
Tax Provision-34,085
Net Income From Continuing Ops-471,077-471,077
Net Income-452,597
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-19,661
 

Technical Analysis of Guizhou Yibai Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Guizhou Yibai Pharmaceutical Co Ltd. The general trend of Guizhou Yibai Pharmaceutical Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Guizhou Yibai Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guizhou Yibai Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4.47 < 4.58 < 4.91.

The bearish price targets are: 3.8.

Tweet this
Guizhou Yibai Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guizhou Yibai Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guizhou Yibai Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guizhou Yibai Pharmaceutical Co Ltd. The current macd is -0.16783023.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guizhou Yibai Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Guizhou Yibai Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Guizhou Yibai Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Guizhou Yibai Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGuizhou Yibai Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guizhou Yibai Pharmaceutical Co Ltd. The current adx is 26.84.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Guizhou Yibai Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Guizhou Yibai Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guizhou Yibai Pharmaceutical Co Ltd. The current sar is 4.80077207.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Guizhou Yibai Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guizhou Yibai Pharmaceutical Co Ltd. The current rsi is 29.68. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Guizhou Yibai Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartGuizhou Yibai Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guizhou Yibai Pharmaceutical Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guizhou Yibai Pharmaceutical Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Guizhou Yibai Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartGuizhou Yibai Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guizhou Yibai Pharmaceutical Co Ltd. The current cci is -197.40552735.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Guizhou Yibai Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartGuizhou Yibai Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guizhou Yibai Pharmaceutical Co Ltd. The current cmo is -48.9567165.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Guizhou Yibai Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGuizhou Yibai Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guizhou Yibai Pharmaceutical Co Ltd. The current willr is -91.96428571.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Guizhou Yibai Pharmaceutical Co Ltd Daily Williams %R ChartGuizhou Yibai Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guizhou Yibai Pharmaceutical Co Ltd.

Guizhou Yibai Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guizhou Yibai Pharmaceutical Co Ltd. The current atr is 0.17768985.

Guizhou Yibai Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartGuizhou Yibai Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guizhou Yibai Pharmaceutical Co Ltd. The current obv is 458,094,291.

Guizhou Yibai Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartGuizhou Yibai Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guizhou Yibai Pharmaceutical Co Ltd. The current mfi is 38.22.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Guizhou Yibai Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartGuizhou Yibai Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guizhou Yibai Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Guizhou Yibai Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guizhou Yibai Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.678
Ma 20Greater thanMa 504.609
Ma 50Greater thanMa 1004.590
Ma 100Greater thanMa 2005.144
OpenGreater thanClose3.880
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Guizhou Yibai Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Guizhou Yibai Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Guizhou Yibai Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guizhou Yibai Pharmaceutical Co Ltd

I send you an email if I find something interesting about Guizhou Yibai Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Guizhou Yibai Pharmaceutical Co Ltd.

Receive notifications about Guizhou Yibai Pharmaceutical Co Ltd in your mailbox!